BackGlobeStar Therapeutics Overview

GlobeStar Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GSTC.

Quarterly EBIT

-$193.36K
↑ 84.89% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$797.73K
↑ 57.49% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin